Literature DB >> 25275005

Phenotypic and genotypic analysis of Clostridium difficile isolates: a single-center study.

Yanjiao Zhou1, Carey-Ann D Burnham2, Tiffany Hink3, Lei Chen4, Nurmohammad Shaikh5, Aye Wollam6, Erica Sodergren4, George M Weinstock4, Phillip I Tarr7, Erik R Dubberke8.   

Abstract

Clostridium difficile infections (CDI) are a growing concern in North America, because of their increasing incidence and severity. Using integrated approaches, we correlated pathogen genotypes and host clinical characteristics for 46 C. difficile infections in a tertiary care medical center during a 6-month interval from January to June 2010. Multilocus sequence typing (MLST) demonstrated 21 known and 2 novel sequence types (STs), suggesting that the institution's C. difficile strains are genetically diverse. ST-1 (which corresponds to pulsed-field gel electrophoresis strain type NAP1/ribotype 027) was the most prevalent (32.6%); 43.5% of the isolates were binary toxin gene positive, of which 75% were ST-1. All strains were ciprofloxacin resistant and metronidazole susceptible, and 8.3% and 13.0% of the isolates were resistant to clindamycin and tetracycline, respectively. The corresponding resistance loci, including potential novel mutations, were identified from the whole-genome sequencing (WGS) of the resistant strains. Core genome single nucleotide polymorphisms (SNPs) determining the phylogenetic relatedness of the 46 strains recapitulated MLST types and provided greater interstrain differentiation. The disease severity was greatest in patients infected with ST-1 and/or binary gene-positive strains, but genome-wide SNP analysis failed to provide additional associations with CDI severity within the same STs. We conclude that MLST and core genome SNP typing result in the same phylogenetic grouping of the 46 C. difficile strains collected in a single hospital. WGS also has the capacity to differentiate those strains within STs and allows the comparison of strains at the individual gene level and at the whole-genome level.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25275005      PMCID: PMC4313296          DOI: 10.1128/JCM.02115-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada.

Authors:  Duncan R MacCannell; Thomas J Louie; Dan B Gregson; Michel Laverdiere; Annie-Claude Labbe; Felicia Laing; Scott Henwick
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

3.  Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Authors:  Faisal Alasmari; Sondra M Seiler; Tiffany Hink; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Clin Infect Dis       Date:  2014-04-21       Impact factor: 9.079

Review 4.  Toxin A-negative, toxin B-positive Clostridium difficile.

Authors:  Denise Drudy; Séamus Fanning; Lorraine Kyne
Journal:  Int J Infect Dis       Date:  2006-07-20       Impact factor: 3.623

5.  Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli.

Authors:  Katrine Grimstrup Joensen; Flemming Scheutz; Ole Lund; Henrik Hasman; Rolf S Kaas; Eva M Nielsen; Frank M Aarestrup
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

Review 6.  Clostridium difficile toxin synthesis is negatively regulated by TcdC.

Authors:  B Dupuy; R Govind; A Antunes; S Matamouros
Journal:  J Med Microbiol       Date:  2008-06       Impact factor: 2.472

7.  Versatile and open software for comparing large genomes.

Authors:  Stefan Kurtz; Adam Phillippy; Arthur L Delcher; Michael Smoot; Martin Shumway; Corina Antonescu; Steven L Salzberg
Journal:  Genome Biol       Date:  2004-01-30       Impact factor: 13.583

8.  Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors.

Authors:  Erik R Dubberke; Kimberly A Reske; Yan Yan; Margaret A Olsen; L Clifford McDonald; Victoria J Fraser
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

9.  Sequence similarity of Clostridium difficile strains by analysis of conserved genes and genome content is reflected by their ribotype affiliation.

Authors:  Hedwig Kurka; Armin Ehrenreich; Wolfgang Ludwig; Marc Monot; Maja Rupnik; Frederic Barbut; Alexander Indra; Bruno Dupuy; Wolfgang Liebl
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

10.  Toxinotype V Clostridium difficile in humans and food animals.

Authors:  Michael A Jhung; Angela D Thompson; George E Killgore; Walter E Zukowski; Glenn Songer; Michael Warny; Stuart Johnson; Dale N Gerding; L Clifford McDonald; Brandi M Limbago
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more
  16 in total

1.  Ceftolozane-tazobactam activity against phylogenetically diverse Clostridium difficile strains.

Authors:  Mark D Gonzalez; Meghan A Wallace; Tiffany Hink; Erik R Dubberke; Carey-Ann D Burnham
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

2.  Multilocus Variable-Number Tandem-Repeat Analysis of Clostridioides difficile Clusters in Ribotype 027 Isolates and Lack of Association with Clinical Outcomes.

Authors:  Julian R Garneau; Claire Nour Abou Chakra; Louis-Charles Fortier; Annie-Claude Labbé; Andrew E Simor; Wayne Gold; Matthew Muller; Allison McGeer; Jeff Powis; Kevin Katz; Jacques Pépin; Louis Valiquette
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

3.  A Discrete Event Simulation Model of Patient Flow in a General Hospital Incorporating Infection Control Policy for Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE).

Authors:  Erica S Shenoy; Hang Lee; Erin E Ryan; Taige Hou; Rochelle P Walensky; Winston Ware; David C Hooper
Journal:  Med Decis Making       Date:  2017-06-29       Impact factor: 2.583

Review 4.  Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027.

Authors:  Larry K Kociolek; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

Review 5.  Epidemiological aspects of healthcare-associated infections and microbial genomics.

Authors:  C Mirande; I Bizine; A Giannetti; N Picot; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-17       Impact factor: 3.267

Review 6.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

7.  Comparative genomics analysis of Clostridium difficile epidemic strain DH/NAP11/106.

Authors:  Larry K Kociolek; Dale N Gerding; David W Hecht; Egon A Ozer
Journal:  Microbes Infect       Date:  2018-01-31       Impact factor: 2.700

8.  Clostridioides difficile Whole-genome Sequencing Differentiates Relapse With the Same Strain From Reinfection With a New Strain.

Authors:  Janice Cho; Scott Cunningham; Meng Pu; Ryan J Lennon; Jennifer Dens Higano; Patricio Jeraldo; Priya Sampathkumar; Samantha Shannon; Purna C Kashyap; Robin Patel
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

Review 9.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

10.  Evaluation of a Combined Multilocus Sequence Typing and Whole-Genome Sequencing Two-Step Algorithm for Routine Typing of Clostridioides difficile.

Authors:  Mini Kamboj; Tracy McMillen; Mustafa Syed; Hoi Yan Chow; Krupa Jani; Anoshe Aslam; Jennifer Brite; Brian Fanelli; Nur A Hasan; Manoj Dadlani; Lars Westblade; Ahmet Zehir; Matthew Simon; N Esther Babady
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.